Personalized follow-up to prevent type 2 diabetes
Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes
This study is testing whether personalized support from a nurse can help people at risk of type 2 diabetes in France make lifestyle changes to prevent the disease.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 230 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Ramsay Générale de Santé Academic / other |
| Locations | 1 site (Biarritz, Aquitaine) |
| Trial ID | NCT05325710 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness of personalized follow-up interventions in preventing type 2 diabetes among at-risk individuals in France. It targets patients with a FINDRISC score of 10 or higher, indicating a higher likelihood of developing diabetes. The intervention involves support from a study nurse to guide lifestyle changes and monitor health. The study seeks to address the underdiagnosis of diabetes and the rising prevalence of the condition due to lifestyle factors.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old with a FINDRISC score of 10 or higher who are beneficiaries of the French health insurance system.
Not a fit: Patients over 75 years old, those already diagnosed with type 2 diabetes, or individuals with severe health impairments will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of type 2 diabetes among at-risk populations.
How similar studies have performed: Other studies have shown promise in using personalized interventions for diabetes prevention, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient, male or female, over the age of 18 * Patient with a FINDRISC score ≥10 points * Beneficiary of a French health insurance system * Patient having been informed and having given their consent free, enlightened and written Exclusion Criteria: * Patient over 75 years old * Patient already diagnosed with type 2 diabetes * Patient whose physical and/or psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant. * Patient participating in another research * Patient in period of exclusion from another research always in progress at the time of inclusion. * Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administration. * Pregnant, breastfeeding or parturient women. * Patient hospitalized without consent
Where this trial is running
Biarritz, Aquitaine
- Clinique Aguiléra — Biarritz, Aquitaine, France (Recruiting)
Study contacts
- Study coordinator: Jf Oudet
- Email: jf.oudet@ecten.eu
- Phone: 068346567
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.